NCT01608178View on ClinicalTrials.gov

Taurine Therapy for SSADH Deficiency

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

April 27, 2012

Study Completion Date

December 16, 2013

Conditions
Succinic Semialdehyde Dehydrogenase
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT01608178 - Taurine Therapy for SSADH Deficiency | Biotech Hunter | Biotech Hunter